Zenyatta Reports on Annual General Meeting

Zenyatta Ventures Ltd. (TSXV: ZEN, “Zenyatta” or the “Company”) reports that it had a successful Annual General and Special Meeting on September 27, 2018 in Toronto, Ontario. The current Board of Directors: Dr. Francis Dube, Brian Bosse, Eric Wallman, Donald Bubar, Frank Klees and Greg Fenton were all re-elected as Directors of the Company. Shareholders also approved an Advance Notice By-Law and a resolution authorizing the Company’s Board to change the name of the Company to Zenyatta Graphene Solutions Ltd. or such other name as the Board of Directors may determine. The name change will better reflect Zenyatta’s new focus on graphene product development. Following the AGM, a new Investor Presentation outlining the graphene opportunity and Zenyatta’s future plans was finalized and uploaded to the Company’s website. It can be found at OUR WEBSITE (click). The Company also announces that it has re-located its Thunder Bay office to Unit 210 at 1205 Amber Drive, Thunder Bay, Ontario, P7B 6M4. The Company can be contacted by phone at 1-705-618-0900. Our email info@zenyatta.cawill remain the same. If you have any questions, please feel free to contact us at the above number or email us at info@zenyatta.ca. Or Dr. Francis Dubé, Co-CEO & Head of Business Development and Technology Tel: +1 (289) 821-2820 Email: fdube@zenyatta.ca
  • Share

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZenGUARD™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Tyler Dunn

Director, Marketing & Communications

tdunn@zentek.com

Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.